Skip to main content
About Us
Image Credits
Contributor Info
RSS
Log In
Join
Twitter
E-Alerts
Visit StemJournal
Main menu
About
Image Credits
Contributor Info
E-Alerts
Chapters
Cellular and nuclear reprogramming
Ectoderm specification and differentiation
Endoderm specification and differentiation
Epigenetics
Genomics and proteomics
Germ cell and somatic stem cell biology in reproduction
Manufacturing
Mesoderm specification and differentiation
Niche biology, homing, and migration
Renewal
Stem cell immunology
Therapeutic prospects
Tissue engineering
Protocols
Ectoderm differentiation
Endoderm differentiation
Genome editing
Mesoderm differentiation
Pluripotent stem cells
PSC characterization
PSC genetic stability
Reprogramming
StemLabs
Stem Cell COREdinates
Core Facility Profiles
Boston Children's Hospital Human Neuron Core
Boston University Center for Regenerative Medicine iPSC Core
Columbia Stem Cell Initiative Stem Cell Core Facility
Harvard Stem Cell Institute iPS Core Facility
Stem Cell Protocols
Stem Cell Reagents
Other Resources
News & Profiles
Latest News
Stem Cell Institute Profiles
Journal Stream
Forum
Search form
Search
You are here
Home
Biblio
Author
Title
[
Type
]
Year
Filters:
Author
is
Sun, Liankang
[Clear All Filters]
Journal Article
Cao J
,
Li J
,
Sun L
,
Qin T
,
Xiao Y
,
Chen K
,
Qian W
,
Duan W
,
Lei J
,
Ma J
, et al.
Hypoxia-driven paracrine osteopontin/integrin αvβ3 signaling promotes pancreatic cancer cell epithelial-mesenchymal transition and cancer stem cell-like properties by modulating FOXM1.
Mol Oncol. 2018.
PubMed
Google Scholar
Yan B
,
Jiang Z
,
Cheng L
,
Chen K
,
Zhou C
,
Sun L
,
Qian W
,
Li J
,
Cao J
,
Xu Q
, et al.
Paracrine HGF/c-MET enhances the stem cell-like potential and glycolysis of pancreatic cancer cells via activation of YAP/HIF-1α.
Exp Cell Res. 2018.
PubMed
Google Scholar
Zhou C
,
Qian W
,
Ma J
,
Cheng L
,
Jiang Z
,
Yan B
,
Li J
,
Duan W
,
Sun L
,
Cao J
, et al.
Resveratrol enhances the chemotherapeutic response and reverses the stemness induced by gemcitabine in pancreatic cancer cells via targeting SREBP1.
Cell Prolif. 2018:e12514.
PubMed
Google Scholar
Cao J
,
Ma J
,
Sun L
,
Li J
,
Qin T
,
Zhou C
,
Cheng L
,
Chen K
,
Qian W
,
Duan W
, et al.
Targeting glypican-4 overcomes 5-FU resistance and attenuates stem cell-like properties via suppression of Wnt/β-catenin pathway in pancreatic cancer cells.
J Cell Biochem. 2018.
PubMed
Google Scholar